• English
  • 简体中文
Login Register
Current Location: Home > Drug Registration and Acceptance subscription Help
-
-
-
Visualized Analysis Export Evaluation Conclusion Evaluation Progress
Acceptance No. Drug Name Active Ingredient Dosage Form Classification Submission Acceptance Date Manufacturers Manufacturers Review Status Status Date View
CXSL2300902 重组带状疱疹疫苗(CHO细胞) Recombinant Zoster Vaccine(CHO Cell) Injection Biological Products(1.3) New Drug Application 2023-12-28 Anhui Zhifei Longcom Biopharmaceutical Co Ltd view
JYSB2400143 重组带状疱疹疫苗(CHO细胞) Recombinant Zoster Vaccine(CHO Cell) Injection Biological Products Supplementary Application 2024-07-04 GlaxoSmithKline Biologicals SA view
CXSL2500282 重组带状疱疹疫苗(CHO细胞) Recombinant Zoster Vaccine(CHO Cell) Injection Biological Products(1.3) New Drug Application 2025-04-10 Anhui Zhifei Longcom Biopharmaceutical Co Ltd view
CXSL2300518 重组带状疱疹疫苗(CHO细胞) Recombinant Zoster Vaccine(CHO Cell) Injection Biological Products(3.3) New Drug Application 2023-07-27 Jiangsu Rec-Biotechnology Co Ltd;Abzymo Biosciences Co Ltd view
CXSL2400311 重组带状疱疹疫苗(CHO细胞) Recombinant Zoster Vaccine(CHO Cell) Injection Biological Products(1.3) New Drug Application 2024-05-14 Yuanda Weixin Life Science (Nanjing) Co Ltd;Yuansai Weixin Life Science (Hangzhou) Co Ltd view
CXSL2400588 重组带状疱疹疫苗(CHO细胞) Recombinant Zoster Vaccine(CHO Cell) Injection Biological Products(1.3) New Drug Application 2024-09-04 Gentize Biotechnology (Jiaxing) Co Ltd view
CXSL2300817 重组带状疱疹疫苗(CHO细胞) Recombinant Zoster Vaccine(CHO Cell) Injection Biological Products(1.3) New Drug Application 2023-11-28 Shanghai Institute of Biological Products Co Ltd view
JYSB2400136 重组带状疱疹疫苗(CHO细胞) Recombinant Zoster Vaccine(CHO Cell) Injection Biological Products Supplementary Application 2024-06-27 GlaxoSmithKline Biologicals SA view
CXSL2500213 重组带状疱疹疫苗(CHO细胞) Recombinant Zoster Vaccine(CHO Cell) Injection Biological Products(1.3) New Drug Application 2025-03-08 Changchun BCHT Biotechnology Co view
CXSL2300431 重组带状疱疹疫苗(CHO细胞) Recombinant Zoster Vaccine(CHO Cell) Injection Biological Products(1.2) New Drug Application 2023-06-27 Beijing Varnotech Biopharm Ltd;Huanuotai Biomedical Technology (Chengdu) Co Ltd view
CXSL2400153 重组带状疱疹疫苗(CHO细胞) Recombinant Zoster Vaccine(CHO Cell) Injection Biological Products(1.2) New Drug Application 2024-02-23 Jiangsu Zhonghui Yuantong Biotechnology Co Ltd;Yihui Biotechnology (Shanghai) Co Ltd view
JYSB2400172 重组带状疱疹疫苗(CHO细胞) Recombinant Zoster Vaccine(CHO Cell) Injection Biological Products Supplementary Application 2024-08-09 GlaxoSmithKline Biologicals SA view
CXSL2400350 重组带状疱疹疫苗(CHO细胞) Recombinant Zoster Vaccine(CHO Cell) Injection Biological Products(1.2) New Drug Application 2024-05-28 Jiangsu Zhonghui Yuantong Biotechnology Co Ltd;Yihui Biotechnology (Shanghai) Co Ltd view
CXSS2500027 重组带状疱疹疫苗(CHO细胞) Recombinant Zoster Vaccine(CHO Cell) Injection Biological Products(1.2) New Drug Application 2025-02-09 Green Bamboo Biopharmaceutical (Zhuhai) Co Ltd view
CXSL2101408 重组带状疱疹疫苗(CHO细胞) Recombinant Zoster Vaccine(CHO Cell) Injection Biological Products(1.3) New Drug Application 2021-11-03 MaxHealth Biotechnology Limited Liability Company;Shanghai Maikekang Biotechnology Co Ltd view
JXSS2400007 重组带状疱疹疫苗(CHO细胞) Recombinant Zoster Vaccine(CHO Cell) Injection Biological Products(3.1) Import Drug Application 2024-02-03 GlaxoSmithKline Biologicals SA view
CXSL2400467 重组带状疱疹疫苗(CHO细胞) Recombinant Zoster Vaccine(CHO Cell) Injection Biological Products(1.2) New Drug Application 2024-07-19 Yantai Patronus Biotech Co Ltd;Guangzhou Patronus Biotech Co Ltd view
JYSB2500120 重组带状疱疹疫苗(CHO细胞) Recombinant Zoster Vaccine(CHO Cell) Injection Biological Products Supplementary Application 2025-05-23 GlaxoSmithKline Biologicals SA view
CXSL2300818 重组带状疱疹疫苗(CHO细胞) Recombinant Zoster Vaccine(CHO Cell) Injection Biological Products(1.3) New Drug Application 2023-11-28 Shanghai Institute of Biological Products Co Ltd view
JYSB2400260 重组带状疱疹疫苗(CHO细胞) Recombinant Zoster Vaccine(CHO Cell) Injection Biological Products Supplementary Application 2024-12-13 GlaxoSmithKline Biologicals SA view